Paul G. Richardson, MD, on Using Elotuzumab After Initial Therapy for Multiple Myeloma

Posted: Tuesday, July 2, 2019

For patients with biochemical disease progression after initial therapy for myeloma, would you consider combination therapy with a monoclonal antibody such as elotuzumab?